Latest news with #Amesite
Yahoo
17-05-2025
- Business
- Yahoo
Amesite Third Quarter 2025 Earnings: US$0.16 loss per share (vs US$0.56 loss in 3Q 2024)
Net loss: US$663.4k (loss narrowed by 54% from 3Q 2024). US$0.16 loss per share (improved from US$0.56 loss in 3Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Amesite shares are up 37% from a week ago. It is worth noting though that we have found 5 warning signs for Amesite that you need to take into consideration. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Associated Press
16-05-2025
- Business
- Associated Press
Amesite Announces Quarterly Revenue Increase of 2.4x in 10-Q Filing
DETROIT, May 16, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced its flagship app NurseMagicTM generated 2.4x revenue from Q2/2025 to Q3/2025, even as the company continued to cut operating expenses. Sarah Berman, Principal Financial and Accounting Officer, said, 'Our revenues are presently evenly distributed between B2B and B2C sales. Following the launch of NurseMagicTM in Q4/2024, revenues were stable from Q1/2025 to Q2/2025. However, in Q3/2025, we had a significant increase of 2.4x in revenue, following execution of targeted sales and marketing motions and rollouts of product enhancements. We also further reduced expenses while scaling sales this past quarter, retaining our strong focus on achieving further operational efficiencies and managing margins to drive to profitability.' Brandon Owens, VP of Sales, said, 'We delivered Teams Plus+ to our B2B customers in direct response to their need for greater intensity of usage, and expect accelerated business demands for more services, given the feedback. Our product testimonials are our best sales assets, and we are closing sales and onboarding teams within days or weeks, because of the efficiency of our payments and onboarding workflows.' Madison Bush, Director of Corporate Operations, said, 'We saw user growth of 1340% over Q3, following the launch of paid subscriptions in Q2. We have expanded our mobile marketing and are communicating with our users at every step of their journey to attract and retain them. We are thrilled to see that nurses who are searching for AI-tools are finding and using NurseMagicTM because it delivers incredible value. ' Dr. Ann Marie Sastry, CEO and Founder, said, 'We are confident that we can continue to deliver NurseMagicTM at an affordable price point to both B2C and B2B customers, while maintaining healthy margins – and look forward to more growth in Q4. Our outstanding customer feedback validates a strong product-market fit. With our nimble development process, we feel that we are in very good position to grow revenue efficiently, while delivering tiered services that enable us to expand into new segments opportunistically.' Amesite is focused on delivering value in large, growing segments, including the 16,700 Skilled Nursing and Home Health Care Facilities in the U.S., employing 1.38 million workers, and 8,514 hospice organizations employing 407,692 workers. With a total of 5.2 million RNs and 630,000 LPNs in the U.S., and demand rising across Senior Living, Skilled Nursing, and Hospice, Amesite is positioned with solutions that meet real needs. Recent rollouts include delivering to the growing hospice segment, meeting HIPAA requirements for all users, and offering a new, higher-priced tier for B2B users. About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagicTM, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagicTM is used by over 100 professions to improve care, enhanced operational efficiency and improved financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as 'may,' 'will,' 'should,' 'would,' 'expect,' 'plan,' 'believe,' 'intend,' 'look forward,' and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations [email protected]
Yahoo
16-05-2025
- Business
- Yahoo
Amesite Announces Quarterly Revenue Increase of 2.4x in 10-Q Filing
Company Reports Accelerated Growth for both B2C and B2B, with Outstanding Customer Reviews into Q4 DETROIT, May 16, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced its flagship app NurseMagicTM generated 2.4x revenue from Q2/2025 to Q3/2025, even as the company continued to cut operating expenses. Sarah Berman, Principal Financial and Accounting Officer, said, 'Our revenues are presently evenly distributed between B2B and B2C sales. Following the launch of NurseMagicTM in Q4/2024, revenues were stable from Q1/2025 to Q2/2025. However, in Q3/2025, we had a significant increase of 2.4x in revenue, following execution of targeted sales and marketing motions and rollouts of product enhancements. We also further reduced expenses while scaling sales this past quarter, retaining our strong focus on achieving further operational efficiencies and managing margins to drive to profitability.' Brandon Owens, VP of Sales, said, 'We delivered Teams Plus+ to our B2B customers in direct response to their need for greater intensity of usage, and expect accelerated business demands for more services, given the feedback. Our product testimonials are our best sales assets, and we are closing sales and onboarding teams within days or weeks, because of the efficiency of our payments and onboarding workflows." Madison Bush, Director of Corporate Operations, said, "We saw user growth of 1340% over Q3, following the launch of paid subscriptions in Q2. We have expanded our mobile marketing and are communicating with our users at every step of their journey to attract and retain them. We are thrilled to see that nurses who are searching for AI-tools are finding and using NurseMagicTM because it delivers incredible value.' Dr. Ann Marie Sastry, CEO and Founder, said, 'We are confident that we can continue to deliver NurseMagicTM at an affordable price point to both B2C and B2B customers, while maintaining healthy margins – and look forward to more growth in Q4. Our outstanding customer feedback validates a strong product-market fit. With our nimble development process, we feel that we are in very good position to grow revenue efficiently, while delivering tiered services that enable us to expand into new segments opportunistically.' Amesite is focused on delivering value in large, growing segments, including the 16,700 Skilled Nursing and Home Health Care Facilities in the U.S., employing 1.38 million workers, and 8,514 hospice organizations employing 407,692 workers. With a total of 5.2 million RNs and 630,000 LPNs in the U.S., and demand rising across Senior Living, Skilled Nursing, and Hospice, Amesite is positioned with solutions that meet real needs. Recent rollouts include delivering to the growing hospice segment, meeting HIPAA requirements for all users, and offering a new, higher-priced tier for B2B users. About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagicTM, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagicTM is used by over 100 professions to improve care, enhanced operational efficiency and improved financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations ir@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
11-03-2025
- Business
- Associated Press
Amesite Announces Successful Soft Rollout of NurseMagic™ Caregiver Solution, Expanding Its Addressable Market for Enterprise by 50%
DETROIT, March 11, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the early adoption of its non-clinical caregiver tool in NurseMagic™. The Caregiver NurseMagic™ Solution directly supports non-clinical workers in their day-to-day jobs, reducing the need for intensive intervention by management, and improving documentation, communication and patient care. Amesite sales are focused on home health care and skilled nursing. Agencies and corporations in these segments employ both clinical and non-clinical staff. Broadly, there are almost 3 million home health care and skilled nursing staff in the U.S., of which over 1.5 million are non-clinical healthcare support workers. By expanding NurseMagic™ solutions to meet the needs of non-clinical workers, Amesite estimates that it has expanded its addressable market for enterprise sales alone by around 50%. Amesite reports that an increasing number of customers have adopted NurseMagic™ for their entire teams, which include non-clinical staff such as CNAs, chaplains, social workers and nurse aides. Over the last three months, Amesite reported that its contracts with hospice providers have grown by over 3,000%, and contract sizes have increased by nearly 1,000%. This comes on the heels of Amesite's recent rollout of its automated purchase process that enables contract expansion with a few clicks, substantially shortening its sales cycle as it outreaches the over 50,000 businesses in its target segments. Brandon Owens, VP of Sales at Amesite, stated, 'We are accelerating contract closures, increasing deal sizes, and expanding existing agreements with a growing suite of features. Organizations that deploy our platform across their entire workforce realize a disproportionate advantage—dramatically reducing audit risk and operational costs. By delivering the right NurseMagic™ solution to every employee, we empower agencies and corporations to seamlessly scale their contracts to cover 100% of their workforce with just a few clicks.' Kalie Wortinger, Senior Manager of Engineering, said, 'We built our infrastructure to be able to train our proprietary AI with extreme speed and accuracy, while meeting HIPAA requirements. We plan to roll out several new tools in the coming months to address market needs, informed by engagement with a rapidly growing cohort of customers and sales prospects.' Amesite CEO Dr. Ann Marie Sastry stated, 'We firmly believe that AI will ultimately support 100% of the U.S. workforce. Healthcare—rife with inefficiencies and unmet needs—is a prime market for Amesite's solutions, including NurseMagic™. With dozens of under- or unserved segments, we have an enormous opportunity to drive impact for our customers and generate revenue.' About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagic™, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic™ is used by over 100 professions, improved care, enhanced operational efficiency and improved financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as 'may,' 'will,' 'should,' 'would,' 'expect,' 'plan,' 'believe,' 'intend,' 'look forward,' and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Yahoo
25-02-2025
- Business
- Yahoo
Amesite Announces Enterprise Sales Growth with Automated Sales Flow for NurseMagic™ Business Customers
Automated Sales Process Has Successfully Enabled NurseMagic™ Enterprise Sales to Close within Hours of Enterprise Outreach DETROIT, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the success of its automated sales flow of its enterprise solution, NurseMagic™ for Teams. Customers in three segments, home care, home health care and hospice, have successfully used the system across the U.S. Implementation of the new purchase flow has cut the time to close an enterprise sale by over 95%. Collectively, these segments represent an addressable market of over $360 billion dollars annually1,2,3, with over 50,000 U.S. businesses. Enterprise customers can initiate and complete their NurseMagic™ subscription within minutes of engaging with Amesite's sales team. This accelerates sales conversion and adoption while enabling customers to onboard their teams immediately – reducing audit risk, employee turnover, and negative client and patient reviews. Customers can also seamlessly add licenses to their NurseMagic™ for Teams package as they expand –whether in-app via the Apple Store or directly on the NurseMagic™ website. NurseMagic™ is an AI-powered solution designed to reduce documentation burdens, enhance patient communication, and improve workflow efficiency for nurses and caregivers. With the introduction of NurseMagic™ for Teams, enterprise healthcare organizations can seamlessly onboard, customize, and deploy NurseMagic™ within their operations – without the friction of traditional lengthy procurement cycles. 'Speed matters in enterprise sales, especially in healthcare, where time saved translates directly to better patient care,' said Dr. Ann Marie Sastry, Founder and CEO of Amesite. 'With our successful, automated sales flow, healthcare organizations are onboarding employees onto the NurseMagic™ app in record time, ensuring their teams can start experiencing efficiency gains immediately.' 'We have already delivered wins in three key market segments,' said Brandon Owens, Vice President of Sales at Amesite. 'With over 50,000 businesses to serve, we are committed to streamlining the purchase and onboarding processes for NurseMagic™ –allowing us to expand into these and other healthcare verticals efficiently and quickly. Our new online purchase capability empowers customers to seamlessly scale their operations, add licenses as they grow, and continue delivering the highest level of care with efficiency and ease.' Kalie Wortinger, Amesite's Senior Engineering Manager added, 'We have built NurseMagic™'s infrastructure to deliver into dozens of care settings. Businesses can now purchase NurseMagic™ subscriptions for their entire teams with a few clicks online. Additionally, our enterprise administrative functions are simple to use. This enables perfect documentation, smooth audits – and approved reimbursements." The Automated Sales Flow streamlines the process from initial inquiry to implementation, offering: Instant Subscription Activation: Enterprise customers can initiate and complete the subscription process in minutes. Manage, Store, and Report All Notes: Organizations can efficiently document, store, and access patient care information with secure reporting features. Manage Access for All Users: Healthcare teams can control access and permissions for streamlined team collaboration. Meet HIPAA Regulations: Ensures compliance with healthcare data security standards. Share Notes with Care Team Members: Facilitates better communication and coordination among healthcare professionals. As demand for home-based care continues to rise, healthcare organizations are increasingly seeking solutions that streamline operations while maintaining high-quality patient care. With this launch, Amesite continues to drive AI-powered transformation across industries, ensuring that organizations can rapidly deploy best-in-class solutions to enhance operational efficiency and workforce productivity. This announcement follows successful launches of Meeting HIPAA Regulation, Paid Consumer Subscriptions, and Enterprise Sales to Large Franchisees as Amesite continues to expand its reach both vertically and horizontally across healthcare. The company's stated ambition is to transform the healthcare industry, which promises a $600 billion opportunity for transformation by AI by 2034. About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $360 billion home, hospice and healthcare segments. Its flagship product, NurseMagic™, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic™ is used by over 100 professions, improved care, enhanced operational efficiency and improved financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic™ meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations ir@ Sources
